TNF and fibrosarcoma: Considering that a comparable dose of TNF is inactive in the WEHI-fibrosarcoma model [38], these results suggest that the G4 moiety of the conjugate, like CNGRC, can indeed enable the targeted delivery of TNF to the tumor vasculature.